Understanding STXBP5L: Potential Drug Target Or Biomarker (G9515)

Target Name: STXBP5L

NCBI ID: G9515

STXBP5L

Understanding STXBP5L: Potential Drug Target Or Biomarker

STXBP5L (Lethal(2) Giant Larvae Protein Homolog 4) is a protein that is expressed in the larvae of the South American caterpillar, Geophilus protervans. It is a member of the Geophilus protein family, which is known for the production of a variety of unique proteins that are involved in the caterpillar's immune system and other biological processes.

Recent studies have suggested that STXBP5L may have potential as a drug target or biomarker. One of the reasons for this is the fact that STXBP5L has been shown to play a role in the caterpillar's immune response. In particular, it has been shown to be involved in the production of a variety of proteins that are involved in the production of antibodies, which are proteins that are designed to recognize and neutralize foreign substances like viruses or bacteria.

Another reason for the potential drug-targeting potential of STXBP5L is its role in the regulation of cell growth. Studies have shown that STXBP5L plays a role in the regulation of cell growth and division, which can be important for the development of cancer. Additionally, STXBP5L has also been shown to be involved in the regulation of cell survival, which can also be important for the development of cancer.

In addition to its potential role in the immune response and cell regulation, STXBP5L has also been shown to have other potential drug-targeting properties. For example, it has been shown to interact with a variety of different proteins, including some that are involved in the development of cancer. Additionally, STXBP5L has been shown to be expressed in a variety of different tissues and cells, which could make it an attractive target for drugs that are designed to target a specific type of cancer or disease.

Overall, the potential drug-targeting and biomarker properties of STXBP5L make it an intriguing protein that may have important clinical applications in the future. Further research is needed to fully understand its role in the immune response and cell regulation, as well as its potential as a drug target or biomarker.

Protein Name: Syntaxin Binding Protein 5L

Functions: Plays a role in vesicle trafficking and exocytosis inhibition. In pancreatic beta-cells, inhibits insulin secretion probably by interacting with and regulating STX1A and STX4, key t-SNARE proteins involved in the fusion of insulin granules to the plasma membrane. Also plays a role in neurotransmitter release by inhibiting basal acetylcholine release from axon terminals and by preventing synaptic fatigue upon repetitive stimulation (By similarity). Promotes as well axonal outgrowth (PubMed:25504045)

The "STXBP5L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STXBP5L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets